J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday and also increased its full-year sales and profit forecast. The post J&J quarterly earnings beat Wall…
Read the full articleYou might also wanna read
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
By Michael Erman July 15 (Reuters) - Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as stron
Why Johnson & Johnson (JNJ) Stock Declined Despite Strong Q2 Earnings Beat
Johnson & Johnson (JNJ) shares fell 2% despite beating Q2 estimates with $2.90 EPS and $25.31B revenue, while raising full-year guidance on
J&J Stock Slips Despite Earnings Beat as Company Raises Guidance Toward $100 Billion Sales Milestone Today
Johnson & Johnson's stock fell despite exceeding Q2 earnings expectations, as investor optimism had already been priced in. The company rais
STATEMENT: J&J Smashes Revenue Records While A Record High Percentage of Americans Struggle To Afford Prescription Drugs
Washington, D.C. – Today, Johnson and Johnson reported their sales for the first half of 2026 — a record high $49.4 billion — keeping the co
J&J MedTech growth slows again in Q2 as Abiomed weighs on results
Johnson & Johnson’s MedTech business posted operational sales growth of 3.6% in the second quarter, reaching $8.93 billion, as weaker Abiome
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
NEW YORK, July 12, 2026, 4:33 p.m. EDT — Healthcare stocks head into the week with Johnson & Johnson, UnitedHealth and Abbott set to gauge w
Comments
Sign in to join the conversation.
No comments yet. Be the first.